Literature DB >> 22841322

Prostate cancer: send away the PSA?

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22841322     DOI： 10.1016/S0140-6736(12)61232-X

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

Review 1.  Potential utility of cancer-specific biomarkers for assessing response to hormonal treatments in metastatic prostate cancer.

Authors:  Jack Schalken; Siebren Dijkstra; Edwina Baskin-Bey; Inge van Oort
Journal:  Ther Adv Urol       Date:  2014-12

2.  Circulating tumor cells in prostate cancer: Precision diagnosis and therapy.

Authors:  Weiwei Liu; Binbin Yin; Xuchu Wang; Pan Yu; Xiuzhi Duan; Chunhua Liu; Ben Wang; Zhihua Tao
Journal:  Oncol Lett       Date:  2017-06-07       Impact factor: 2.967

3.  The establishment and evaluation of a new model for the prediction of prostate cancer.

Authors:  Qi Wang; Yan-Feng Li; Jun Jiang; Yong Zhang; Xu-Dong Liu; Ke Li
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.